 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 September 2000 | Volume 133 Issue 6 | Pages 447-454
Purpose: To review reported inflammatory reactions occurring after initiation of highly active antiretroviral therapy (HAART) in persons infected with HIV-1 and to explore the mechanisms leading to these reactions.
Data Sources: MEDLINE search of biomedical literature reporting inflammatory reactions after HAART. Bibliographies of retrieved reports were also reviewed.
Study Selection: Articles describing patients infected with HIV-1 who had immunologic and virologic responses to HAART and subsequently developed inflammatory reactions.
Data Extraction: Data on the immune status, clinical characteristics, and therapeutic management of patients who were seropositive for HIV-1 and had inflammatory reactions after HAART.
Data Synthesis: Inflammatory reactions involving opportunistic infections, AIDS-associated malignant conditions, and other noninfectious diseases have recently been described in patients infected with HIV-1. These conditions often appeared shortly after the introduction of HAART and were associated with pronounced reductions in plasma HIV-1 viral load and increases in CD4+ T-lymphocyte counts. Clinical presentation was often atypical of that in patients with untreated HIV-1 infection, probably because of restored immunity. Most cases improved despite continuation of HAART, although some patients required anti-inflammatory drugs or specific antimicrobial agents.
Conclusions: Clinicians caring for patients who are infected with HIV-1 and receiving HAART must be aware of this new and diverse clinical syndrome. As more HAART recipients are studied, new presentations will probably be observed.
Author and Article Information
From Thomas Jefferson University, Philadelphia, Pennsylvania.
Requests for Single Reprints: Roger J. Pomerantz, MD, Division of Infectious Diseases, Department of Medicine, Thomas Jefferson University, 1020 Locust Street, Suite 329, Philadelphia, PA 19107-6799; e-mail, roger.j.pomerantz{at}mail.tju.edu.
Current Author Addresses: Drs. DeSimone and Babinchak: Division of Infectious Diseases, Department of Medicine, Thomas Jefferson University, 125 South Ninth Street, Suite 402, Philadelphia, PA 19107.
Dr. Pomerantz: Division of Infectious Diseases, Department of Medicine, Thomas Jefferson University, 1020 Locust Street, Suite 329, Philadelphia, PA 19107-6799. REVIEW
Inflammatory Reactions in HIV-1–Infected Persons after Initiation of Highly Active Antiretroviral Therapy
This article has been cited by other articles:
|
|
 |
|
  K. L Ortega, A. Ceballos-Salobrena, L. A Gaitan-Cepeda, and M. G Magalhaes Oral manifestations after immune reconstitution in HIV patients on HAART Int J STD AIDS, May 1, 2008; 19(5): 305 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Liang Evaluation of change in CD4+ cell counts in AIDS clinical trials Statistical Methods in Medical Research, April 1, 2008; 17(2): 141 - 150. [Abstract] [PDF]
|
|
|
|
 |
|
 R. E. Davaro and A. Thirumalai Life-Threatening Complications of HIV Infection J Intensive Care Med, March 1, 2007; 22(2): 73 - 81. [Abstract] [PDF]
|
|
|
|
 |
|
 L. McKinley, A. J. Logar, F. McAllister, M. Zheng, C. Steele, and J. K. Kolls Regulatory T Cells Dampen Pulmonary Inflammation and Lung Injury in an Animal Model of Pneumocystis Pneumonia J. Immunol., November 1, 2006; 177(9): 6215 - 6226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. A. Stringer, I. Zulu, J. Levy, E. M. Stringer, A. Mwango, B. H. Chi, V. Mtonga, S. Reid, R. A. Cantrell, M. Bulterys, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA, August 16, 2006; 296(7): 782 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Venkataramana, C. A. Pardo, J. C. McArthur, D. A. Kerr, D. N. Irani, J. W. Griffin, P. Burger, D. S. Reich, P. A. Calabresi, and A. Nath Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients Neurology, August 8, 2006; 67(3): 383 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Shelburne, M. Montes, and R. J. Hamill Immune reconstitution inflammatory syndrome: more answers, more questions J. Antimicrob. Chemother., February 1, 2006; 57(2): 167 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Rajendran, J. C. Dolev, M. R. Heaphy Jr, and T. Maurer Eosinophilic Folliculitis: Before and After the Introduction of Antiretroviral Therapy Arch Dermatol, October 1, 2005; 141(10): 1227 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Dlodlo, P. I. Fujiwara, and D. A. Enarson Should tuberculosis treatment and control be addressed differently in HIV-infected and -uninfected individuals? Eur. Respir. J., April 1, 2005; 25(4): 751 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The Antiretroviral Therapy Cohort Collaboration* The Changing Incidence of AIDS Events in Patients Receiving Highly Active Antiretroviral Therapy Arch Intern Med, February 28, 2005; 165(4): 416 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. S. PEREIRA, M. M. A. STEFANI, J. A. ARAUJO FILHO, L. C. S. SOUZA, G. P. STEFANI, and C. M. T. MARTELLI HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) AND MYCOBACTERIUM LEPRAE CO-INFECTION: HIV-1 SUBTYPES AND CLINICAL, IMMUNOLOGIC, AND HISTOPATHOLOGIC PROFILES IN A BRAZILIAN COHORT Am J Trop Med Hyg, November 1, 2004; 71(5): 679 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Chen, G Sethi, R Goldin, A R Wright, and C J Lacey Concurrent granulomatous Pneumocystis carinii and Mycobacterium xenopi pneumonia: an unusual manifestation of HIV immune reconstitution disease Thorax, November 1, 2004; 59(11): 997 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Iyasere, J. C. Tilton, A. J. Johnson, S. Younes, B. Yassine-Diab, R.-P. Sekaly, W. W. Kwok, S. A. Migueles, A. C. Laborico, W. L. Shupert, et al. Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 J. Virol., October 15, 2003; 77(20): 10900 - 10909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Trevenzoli, A M Cattelan, F Marino, U Marchioro, and P Cadrobbi Sarcoidosis and HIV infection: a case report and a review of the literature Postgrad. Med. J., September 1, 2003; 79(935): 535 - 538. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Cahn, H. Perez, G. Ben, and C. Ochoa Tuberculosis and HIV: A Partnership Against the Most Vulnerable J Int Assoc Physicians AIDS Care (Chic Ill), July 1, 2003; 2(3): 106 - 123. [Abstract] [PDF]
|
|
|
|
|
|
P. G. Yeni, S. M. Hammer, C. C. J. Carpenter, D. A. Cooper, M. A. Fischl, J. M. Gatell, B. G. Gazzard, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, et al. Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel JAMA, July 10, 2002; 288(2): 222 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.D. Iseman Tuberculosis therapy: past, present and future Eur. Respir. J., July 1, 2002; 20(36_suppl): 87S - 94s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Redington and K. L. Tyler Viral Infections of the Nervous System, 2002: Update on Diagnosis and Treatment Arch Neurol, May 1, 2002; 59(5): 712 - 718. [Full Text] [PDF]
|
|
|
|
|
|
W. M. Geisler, R. D. Harrington, C. K. Wallis, J. P. Harnisch, and W. C. Liles Broad Spectrum of Dermatologic Manifestations Caused by Mycobacterium haemophilum Infection Arch Dermatol, February 1, 2002; 138(2): 229 - 230. [Full Text] [PDF]
|
|
|
|
|
|
E. Navas, P. Martin-Davila, L. Moreno, V. Pintado, J. L. Casado, J. Fortun, M. J. Perez-Elias, E. Gomez-Mampaso, and S. Moreno Paradoxical Reactions of Tuberculosis in Patients With the Acquired Immunodeficiency Syndrome Who Are Treated With Highly Active Antiretroviral Therapy Arch Intern Med, January 14, 2002; 162(1): 97 - 99. [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Wolff and A. E. O'Donnell Pulmonary Manifestations of HIV Infection in the Era of Highly Active Antiretroviral Therapy Chest, December 1, 2001; 120(6): 1888 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Wendel, K. S. Alwood, R. Gachuhi, R. E. Chaisson, W. R. Bishai, and T. R. Sterling Paradoxical Worsening of Tuberculosis in HIV-Infected Persons Chest, July 1, 2001; 120(1): 193 - 197. [Abstract] [Full Text] [PDF]
|
|
Article
